244
Views
1
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Effect of the consumption of β-lactoglobulin and epigallocatechin-3-gallate with or without calcium on glucose tolerance in C57BL/6 mice

, , , &
Pages 298-304 | Received 28 Sep 2015, Accepted 18 Feb 2016, Published online: 10 Mar 2016

References

  • Ahlkvist L, Vikman J, Pacini G, Ahren B. 2012. Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice. Regul Pept. 178:29–35.
  • Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. 2010. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr. 91:966–975.
  • Akhavan T, Luhovyy BL, Panahi S, Kubant R, Brown PH, Anderson GH. 2014. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults. J Nutr Biochem. 25:36–43.
  • Babu PV, Liu D, Gilbert ER. 2013. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 24:1777–1789.
  • Baggio LL, Drucker DJ. 2007. Biology of incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157.
  • Carnovale V, Britten M, Couillard C, Bazinet L. 2015. Impact of calcium on the interactions between epigallocatechin-3-gallate and β-lactoglobulin. Food Res Int. 77:565–571.
  • Coghlan MP, Fairman D. 2013. Therapies for type 2 diabetes: modulating the incretin pathway using small molecule peptidase inhibitors or peptide mimetics. In: Ganellin R, Roberts SM, Jefferies R editors. Introduction to biological and small molecule drug research and development. Oxford (UK): Academic Press. 205–223.
  • Deacon CF. 2004. Circulation and degradation of GIP and GLP-1. Horm Metab Res. 36:761–765.
  • Del Prete A, Iadevaia M, Loguercio C. 2012. The role of gut hormones in controlling the food intake: what is their role in emerging diseases? Endocrinol Nutr. 59:197–206.
  • Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. 2007. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab. 92:4052–4055.
  • Frid AH, Nilsson M, Holst JJ, Bjorck IM. 2005. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 82:69–75.
  • Guéguen L, Pointillart A. 2000. The bioavailability of dietary calcium. J Am Coll Nutr. 19:119S–136S.
  • Gunnarsson PT, Winzell MS, Deacon CF, Larsen MO, Jelic K, Carr RD, Ahren B. 2006. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology. 147:3173–3180.
  • Gunnerud UJ, Ostman EM, Bjorck IM. 2013. Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose-response study. Eur J Clin Nutr. 67:749–753.
  • Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. 2011. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. 16:157–163.
  • International Diabetes Federation. 2013. IDF diabetes atlas, 6th ed. Brussels, Belgium: International Diabetes Federation. http://www.idf.org/diabetesatlas.
  • Jenness R, Koops J. 1962. Preparation and properties of a salt solution which simulates milk ultrafiltrate. Neth Milk Dairy J. 16:153–164.
  • Jing Y, Han G, Hu Y, Bi Y, Li L, Zhu D. 2009. Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med. 24:557–562.
  • Kanakis CD, Hasni I, Bourassa P, Tarantilis PA, Polissiou MG, Tajmir-Riahi HA. 2011. Milk β-lactoglobulin complexes with tea polyphenols. Food Chem. 127:1046–1055.
  • Kokkinos A, Le Roux CW, Alexiadou K, Tentolouris N, Vincent RP, Kyriaki D, Perrea D, Ghatei MA, Bloom SR, Katsilambros N. 2010. Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 95:333–337.
  • Kumar V, Abbas AK, Fausto N, Mitchell RM. 2007. Robbins basic pathology. Philadelphia (PA): W.B. Saunders.
  • Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. J Am Med Assoc. 296:1255–1265.
  • Labbé D, Tremblay A, Bazinet L. 2006. Effect of brewing temperature and duration on green tea catechin solubilization: basis for production of EGC and EGCG-enriched fractions. Sep Purif Technol. 49:1–9.
  • Lan XY, Wang JQ, Bu DP, Shen JS, Zheng N, Sun P. 2010. Effects of heating temperatures and addition of reconstituted milk on the heat indicators in milk. J Food Sci. 75:C653–C658.
  • Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. 2014. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One. 9:e91163
  • McAllan L, Speakman JR, Cryan JF, Nilaweera KN. 2015. Whey protein isolate decreases murine stomach weight and intestinal length and alters the expression of Wnt signalling-associated genes. Br J Nutr. 13:1–8.
  • Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B. 2004. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes. 53:654–662.
  • Mentlein R. 2005. Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. Expert Opin Investig Drugs. 14:57–64.
  • Méric E, Lemieux S, Turgeon SL, Bazinet L. 2014. Insulin and glucose responses after ingestion of different loads and forms of vegetable or animal proteins in protein enriched fruit beverages. J Funct Foods. 10:95–103.
  • Nagle DG, Ferreira D, Zhou YD. 2006. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 67:1849–1855.
  • Nauck M, Stockmann F, Ebert R, Creutzfeldt W. 1986. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 29:46–52.
  • Nicklas TA. 2003. Calcium intake trends and health consequences from childhood through adulthood. J Am Coll Nutr. 22:340–356.
  • Noatsch A, Petzke KJ, Millrose MK, Klaus S. 2011. Body weight and energy homeostasis was not affected in C57BL/6 mice fed high whey protein or leucine-supplemented low-fat diets. Eur J Nutr. 50:479–488.
  • Orskov C, Wettergren A, Holst JJ. 1993. Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes. 42:658–661.
  • Ozdal T, Capanoglu E, Altay F. 2013. A review on protein–phenolic interactions and associated changes. Food Res Int. 51:954–970.
  • Pal S, Radavelli-Bagatini S. 2013. The effects of whey protein on cardiometabolic risk factors. Obes Rev. 14:324–343.
  • Persson K, Gingerich RL, Nayak S, Wada K, Wada E, Ahren B. 2000. Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. Am J Physiol Endocrinol Metab. 279:E956–E962.
  • Shpigelman A, Israeli G, Livney YD. 2010. Thermally-induced protein–polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG. Food Hydrocoll. 24:735–743.
  • Smithers GW. 2008. Whey and whey proteins—From ‘gutter-to-gold’. Int Dairy J. 18:695–704.
  • Stojadinovic M, Radosavljevic J, Ognjenovic J, Vesic J, Prodic I, Stanic-Vucinic D, Cirkovic Velickovic T. 2013. Binding affinity between dietary polyphenols and β-lactoglobulin negatively correlates with the protein susceptibility to digestion and total antioxidant activity of complexes formed. Food Chem. 136:1263–1271.
  • Tong X, Dong JY, Wu ZW, Li W, Qin LQ. 2011. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr. 65:1027–1031.
  • Uchida M, Ohshiba Y, Mogami O. 2011. Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin. J Pharmacol Sci. 117:63–66.
  • Von Staszewski M, Jaraa FL, Ruizb ALTG, Jagusa RJ, Carvalho JE, Pilosofa AMR. 2012. Nanocomplex formation between β-lactoglobulin or caseinomacropeptide and green tea polyphenols: impact on protein gelation and polyphenols antiproliferative activity. J Funct Foods. 4:800–809.
  • Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, Oh DY, Lu M, Milne JC, Westphal C, et al. 2010. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab. 298:E419–E428.
  • Zorilla R, Liang L, Remondetto G, Subirade M. 2011. Interaction of epigallocatechin-3-gallate with β-lactoglobulin: molecular characterization and biological implication. Dairy Sci Technol. 91:629–644.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.